A Qualitative Exploration to Understand Barriers and Facilitators to Daily Oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda
This research was supported by Doris Duke Charitable Foundation Clinician Scientist Development Award (PI, Matthews).
Journal of the International AIDS Society
HIV -- Case studies, AIDS (Disease) -- Treatment -- Uganda, AIDS (Disease) -- Uganda -- Clinical trials, Antiretroviral therapy, AIDS (Disease) -- Patients -- Counseling of
Introduction: Antiretroviral pre-exposure prophylaxis (PrEP) may reduce periconception and pregnancy HIV incidence among women in settings, where gender power imbalances limit HIV testing, engagement in care and HIV viral suppression. We conducted qualitative interviews to understand factors influencing periconception and pregnancy PrEP uptake and use in a cohort of women (Trial registration: NCT03832530) offered safer conception counselling in rural Southwestern Uganda, where PrEP uptake was high. Methods: Between March 2018 and January 2019, in-depth interviews informed by conceptual frameworks for periconception risk reduction and PrEP adherence were conducted with 37 women including those with ≥80% and
Copyright © 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Locate the Document
Atukunda, E. C., Owembabazi, M., Pratt, M. C., Psaros, C., Muyindike, W., Chitneni, P., ... & Matthews, L. T. (2022). A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV‐negative women planning for or with pregnancy in rural Southwestern Uganda. Journal of the International AIDS Society, 25(3), e25894.